Enhancing preventive medicine over curative medicine: Role of telemedicine

Babatunde, Akintunde; Shobanke, Habib Ayomide; Akinade, Abdulsabur Aderemi; Michael, Anayo James; Osadare, Modupe; Akanbi, Oluwatomisin Khadijat; Favour, Obiorah Chioma; Adebisi, Yusuff Adebayo

doi:10.1016/j.puhip.2021.100130

Cited by 7 publications

(3 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…National health and education policies around the world are under severe scrutiny and clinicians are facing major challenges, leading everyone to rethink the importance of preventive medicine and health promotion. Historically, healthcare has been biased towards curative medicine at the expense of preventive care, resulting in high levels of preventable disease and mortality [8].…”

Section: Theoretical Backgroundmentioning

confidence: 99%

Electronic Biometric Detector and body composition index in predicting disease risk

Yang

Ting

2023

Proceedings of International Conference on Artificial Life and Robotics

View full text Add to dashboard Cite

According to the World Health Organization, COVID-19 has killed 14.9 million people worldwide by 2021. According to statistics from the World Obesity Alliance, if the domestic obese population exceeds 50% (three high diseases), the country's COVID-19 mortality rate will be 10 times higher. There seems to be a close relationship between obesity and the risk of hospitalization and treatment. In this study, the electronic biological information detector was used to collect the response values of the body cells of adults in Taiwan. Through the comparison and analysis of big data, the functional status of each organ system in the human body was calculated and compared with the body composition index. It was found that there is a high correlation between the two. The results of this study may provide feasibility of different health risk assessments.

show abstract

Section: Theoretical Backgroundmentioning

confidence: 99%

Electronic Biometric Detector and body composition index in predicting disease risk

Yang

Ting

2023

Proceedings of International Conference on Artificial Life and Robotics

View full text Add to dashboard Cite

show abstract

“…Additionally, preventive medicine plays a crucial role in reducing patient side effects, through proactive measures like routine screenings, vaccinations, lifestyle modifications, and early disease detection. These measures contribute significantly to improving patient well-being [6][7][8]. Furthermore, patient outcomes are not solely determined by medical interventions, but also by education, housing, and access to healthy food [9].…”

Section: Introductionmentioning

confidence: 99%

Biomaterials for Drug Delivery and Human Applications

Trucillo

2024

Materials

View full text Add to dashboard Cite

Biomaterials embody a groundbreaking paradigm shift in the field of drug delivery and human applications. Their versatility and adaptability have not only enriched therapeutic outcomes but also significantly reduced the burden of adverse effects. This work serves as a comprehensive overview of biomaterials, with a particular emphasis on their pivotal role in drug delivery, classifying them in terms of their biobased, biodegradable, and biocompatible nature, and highlighting their characteristics and advantages. The examination also delves into the extensive array of applications for biomaterials in drug delivery, encompassing diverse medical fields such as cancer therapy, cardiovascular diseases, neurological disorders, and vaccination. This work also explores the actual challenges within this domain, including potential toxicity and the complexity of manufacturing processes. These challenges emphasize the necessity for thorough research and the continuous development of regulatory frameworks. The second aim of this review is to navigate through the compelling terrain of recent advances and prospects in biomaterials, envisioning a healthcare landscape where they empower precise, targeted, and personalized drug delivery. The potential for biomaterials to transform healthcare is staggering, as they promise treatments tailored to individual patient needs, offering hope for improved therapeutic efficacy, fewer side effects, and a brighter future for medical practice.

show abstract

“…In developing countries, such as Colombia, it is estimated that coronary heart disease represents more than 4,000 United States dollars (USD) per patient per year to the health system, a figure that increases to 6,000 USD in the case of stroke 7 . The late and inadequate implementation of measures to prevent cardiovascular events is one of the main causes of this disease's increased prevalence, mortality, and high costs 8,9 . One of the most important preventive…”

mentioning

confidence: 99%

External validation of the ACC/AHA ASCVD risk score in a Colombian population cohort

Rodríguez-Ariza

Cabrera-Villamizar

Rodríguez-Pulido

et al. 2023

Sci Rep

View full text Add to dashboard Cite

No cardiovascular risk score has included Latin American patients in its development. The ACC/AHA ASCVD risk score has not been validated in Latin America; consequently, its predictive capacity in the population of the region is unknown. The aim of this study is to evaluate the discrimination capacity and calibration of the ACC/AHA ASCVD score to predict the 10-year risk of a cardiovascular event in a primary prevention cohort followed in a Colombian hospital. A retrospective cohort study was conducted in primary prevention patients belonging to an intermediate/high-risk and low-risk cohort without established atherosclerotic disease. Cardiovascular risk was calculated at inclusion. The calibration was analyzed by comparing observed and expected events in the different risk categories. A discrimination analysis was made using the area under the ROC curve and C statistic. A total of 918 patients were included—202 from the intermediate/high-risk and 716 from the low-risk cohort. The median cardiovascular risk was 3.6% (IQR 1.7–8.5%). At the 10-year follow-up, 40 events (4,4%) occurred. The area under the ROC curve was 0.782 (95% CI 0.71–0.85). The Hosmer–Lemeshow test did not show differences between expected and observed events. The ACC/AHA ASCVD score is calibrated and has good discrimination capacity in predicting 10-year risk of cardiovascular events in a Colombian population.

show abstract

Enhancing preventive medicine over curative medicine: Role of telemedicine

Cited by 7 publications

References 16 publications

Electronic Biometric Detector and body composition index in predicting disease risk

Electronic Biometric Detector and body composition index in predicting disease risk

Biomaterials for Drug Delivery and Human Applications

External validation of the ACC/AHA ASCVD risk score in a Colombian population cohort

Contact Info

Product

Resources

About